PHGE - BiomX Inc.
0.58
-0.006 -1.000%
Share volume: 159,794
Last Updated: 04-04-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$0.59
-0.01
-0.01%
Summary score
19%
Profitability
25%
Dept financing
16%
Liquidity
15%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.44%
Return on assets
3.68%
Return on sales
0%
Return on invested capital
-183.18%
Total debt ratio
37.01%
Debt ratio change over timeo
-1.2%
Current Ratio
20.52%
Quick Ratio
0%
Cash Position Ratio
17.3%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
15.52%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
67.9%
Debt ratio change over timeo
-1.37%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
15.52%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
67.9%
Debt ratio change over time
-1.37%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-95.41%
Return on assets
-102.02%
Return on sales
0%
Return on invested capital
-0.48%
Total debt ratio
-120.2%
Debt ratio change over time
-1.2%
Current Ratio
-12.15%
Quick Ratio
0%
Cash Position Ratio
-10.4%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PHGE | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -8.44% | 18.15% | 2.92% | 4.58% |
| Return on assets | 3.68% | 3.24% | 3.24% | 2.5% |
| Return on sales | 0% | 32.46% | 30.87% | 24.31% |
| Return on invested capital | -183.18% | 5.53% | 1.1% | 4.42% |
| Profitability | 25% | 97% | 55% | 62% |
| Total debt ratio | 37.01% | 90.54% | 68.15% | 49.25% |
| Debt ratio change over time | -1.2% | 17.23% | 106.35% | 3.43% |
| Dept financing | 10% | 29% | 44% | 14% |
| Current Ratio | 0% | 2.18% | 1.19% | 2.26% |
| Quick Ratio | 0% | 1.79% | 1.05% | 1.63% |
| Cash Position Ratio | 0% | 1.28% | 0.5% | 0.61% |
| Liquididy | 50% | 24% | 21% | 29% |
| Short-term ratios | PHGE | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | -0.7% | 1.97% |
| Return on assets | 15.52% | 2.04% | 1.42% | 1.68% |
| Return on sales | 0% | 24.13% | 12.88% | 18.45% |
| Return on invested capital | 0% | 0% | -0.19% | 2.14% |
| Profitability | 25% | 28% | 16% | 72% |
| Total debt ratio | 67.9% | 93.05% | 66.24% | 44.68% |
| Debt ratio change over time | -1.37% | 0% | 11.15% | -12.97% |
| Dept financing | 18% | 25% | 43% | 12% |
| Current Ratio | 0% | 2.18% | 1.19% | 2.26% |
| Quick Ratio | 0% | 1.79% | 1.05% | 1.63% |
| Cash Position Ratio | 0% | 1.28% | 0.5% | 0.61% |
| Liquididy | 0% | 74% | 38% | 60% |
